These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 82767)

  • 21. Biology and biochemistry of thromboxane synthetase inhibitors.
    Gorman RR
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():235-40. PubMed ID: 6221529
    [No Abstract]   [Full Text] [Related]  

  • 22. Thromboxane synthetase inhibition results in increased platelet sensitivity to prostacyclin.
    Bertelé V; Falanga A; Roncaglioni MC; Cerletti C; de Gaetano G
    Thromb Haemost; 1982 Jun; 47(3):294. PubMed ID: 7051411
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
    Vaghi F; Colombo M; Pierucci L; Volpi D; Dho L; Ukmar G; Rosa B; Salvati P
    Drugs Exp Clin Res; 1993; 19(6):249-60. PubMed ID: 8013268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute myocardial infarction: pathogenesis and implications for treatment. Where do we go now?
    Kawai C
    Int J Cardiol; 1988 Jan; 18(1):5-14. PubMed ID: 3277920
    [No Abstract]   [Full Text] [Related]  

  • 25. [Platelet aggregation and antiaggregant drugs].
    Andriani A; Chiappetta MG; Fabiani M
    Recenti Prog Med; 1982 Nov; 73(5):537-42. PubMed ID: 6761807
    [No Abstract]   [Full Text] [Related]  

  • 26. Platelet aggregation in whole blood: the role of thromboxane A2 and adenosine diphosphate.
    Carter AJ; Heptinstall S
    Thromb Haemost; 1985 Oct; 54(3):612-6. PubMed ID: 3937261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective thromboxane synthase inhibition does not increase in vivo synthesis of prostacyclin in healthy humans.
    Vesterqvist O; Gréen K; Henriksson P; Rasmanis G; Edhag O
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():165-8. PubMed ID: 1825536
    [No Abstract]   [Full Text] [Related]  

  • 28. [Problems of a pharmacologic search for inhibitors of platelet aggregation].
    Lakin KM
    Kardiologiia; 1988 Oct; 28(10):120-6. PubMed ID: 3066962
    [No Abstract]   [Full Text] [Related]  

  • 29. Dipyridamole potentiates the inhibition of platelet aggregation by aspirin (in human platelet rich plasma and whole blood).
    Violi F; Praticò D; Iuliano L; Balsano F
    J Lipid Mediat; 1991; 4(1):61-7. PubMed ID: 1909906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
    Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective inhibition by fenflumizole tissue cyclooxygenase in rabbits ex vivo.
    Basista M; Grodzińska L; Gryglewski RJ
    Pol J Pharmacol Pharm; 1985; 37(1):41-6. PubMed ID: 3929239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of prostacyclin in vascular tissue.
    Moncada S; Vane JR
    Fed Proc; 1979 Jan; 38(1):66-71. PubMed ID: 215463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Stimulation of prostacyclin biosynthesis as a possible mechanism of action of dipyridamole (author's transl)].
    Mentz P; Pönicke K; Block HU; Giessler C; Blass KE; Bayer BL; Förster W
    Arzneimittelforschung; 1981; 31(12):2075-82. PubMed ID: 7037009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies of the influence of nitroglycerin on the synthesis of prostaglandins and thromboxane A2 and on platelet aggregation.
    Rettkowski W; Pönicke K; Block HU; Giessler C; Dunemann A; Zehl U; Förster W
    Arzneimittelforschung; 1982; 32(3):194-200. PubMed ID: 6805480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelets and intimal thickening.
    Sumiyoshi A; Asada Y; Marutsuka K; Hayashi T; Kisanuki A; Tsuneyoshi A; Sato Y
    Ann N Y Acad Sci; 1995 Jan; 748():74-85; discussion 85. PubMed ID: 7695225
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of SC 38249, a novel substituted imidazole, on platelet aggregation in vitro and in vivo.
    Lad N; Honey AC; Lunt DO; Booth RF; Westwick J; Manley PW; Tuffin DP
    Thromb Haemost; 1988 Apr; 59(2):164-70. PubMed ID: 3133807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of prostaglandins and thromboxane A2 for the mode of action of cardiovascular drugs.
    Förster W
    Adv Prostaglandin Thromboxane Res; 1980; 7():609-18. PubMed ID: 6989188
    [No Abstract]   [Full Text] [Related]  

  • 38. [Mechanism of changes in the platelet functional activity caused by low energy laser irradiation].
    Spasov AA; Nedogoda VV; Konan K
    Biull Eksp Biol Med; 1998 Jul; 126(7):45-8. PubMed ID: 9777195
    [No Abstract]   [Full Text] [Related]  

  • 39. The novel prostaglandin I2 mimetic ONO-1301 escapes desensitization in an antiplatelet effect due to its inhibitory action on thromboxane A2 synthesis in mice.
    Kashiwagi H; Yuhki K; Kojima F; Kumei S; Takahata O; Sakai Y; Narumiya S; Ushikubi F
    J Pharmacol Exp Ther; 2015 May; 353(2):269-78. PubMed ID: 25740898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulation of prostacyclin release from vessel wall by Bay g 6575, an antithrombotic compound.
    Vermylen J; Chamone DA; Verstraete M
    Lancet; 1979 Mar; 1(8115):518-20. PubMed ID: 85106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.